Sunday, August 12, 2012
Pfizer: Major drug combo trial fails to meet goal of effectively combating cancer - The Petri Dish
The Petri DishPfizer: Major drug combo trial fails to meet goal of effectively combating cancerThe Petri DishAccording to a release from Pfizer, a trial of the drugs Torisel and bevacizumab (Avastin) in combination failed to meet target goals in the treatment of renal cell cancer. In a new trial, called Intoract, the combination of Torisel with bevacizumab ...Pfizer's Torisel drug fails in a combination studyReutersReuters Health News SummaryChicago TribunePfizer: Phase 3 Trial of Torisel
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment